SF3B1 and glioblastoma: SF3B1 expression levels were significantly higher in U-87/U-118 MG cells compared with non-tumor brain tissues (Fig. S4a) and were slightly higher, but comparable, in U-87/U-118 MG cells and GBM samples, suggesting that both cell lines were appropriate GBM models to study SF3B1 functional role.